Cargando…
Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of blindness in the Western world. AMD is a multifactorial disorder but complement-mediated inflammation at the level of the retina plays a pivotal role. Oral zinc supplementation can reduce the progression of AMD but the precise mechanism...
Autores principales: | Smailhodzic, Dzenita, van Asten, Freekje, Blom, Anna M., Mohlin, Frida C., den Hollander, Anneke I., van de Ven, Johannes P. H., van Huet, Ramon A. C., Groenewoud, Joannes M. M., Tian, Yuan, Berendschot, Tos T. J. M., Lechanteur, Yara T. E., Fauser, Sascha, de Bruijn, Chris, Daha, Mohamed R., van der Wilt, Gert Jan, Hoyng, Carel B., Klevering, B. Jeroen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231060/ https://www.ncbi.nlm.nih.gov/pubmed/25393287 http://dx.doi.org/10.1371/journal.pone.0112682 |
Ejemplares similares
-
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2016) -
Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration
por: van de Ven, Johannes P.H., et al.
Publicado: (2012) -
Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema
por: Schreur, Vivian, et al.
Publicado: (2018) -
Complement Activation Levels Are Related to Disease Stage in AMD
por: Heesterbeek, Thomas J., et al.
Publicado: (2020) -
The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective
por: van Asten, Freekje, et al.
Publicado: (2018)